How should I manage insomnia in a 79-year-old female who has had difficulty sleeping for the past week and is already taking trazodone?

Management of Trazodone-Refractory Insomnia in a 79-Year-Old Woman

You should discontinue trazodone and switch to an FDA-approved hypnotic agent, specifically low-dose doxepin (3-6 mg) for sleep maintenance or ramelteon (8 mg) for sleep onset, as the American Academy of Sleep Medicine explicitly recommends against using trazodone for insomnia treatment. 1

Why Trazodone Should Be Discontinued

The 2017 American Academy of Sleep Medicine clinical practice guideline makes a clear recommendation: clinicians should NOT use trazodone as a treatment for sleep onset or sleep maintenance insomnia 1. This is critical because:

• Trazodone is FDA-approved only for major depressive disorder, not insomnia 2
• The evidence quality for trazodone in insomnia is insufficient to support its use
• Your patient has already failed on trazodone for one week, demonstrating lack of efficacy

Immediate Assessment Before Switching

Before changing medications, quickly evaluate:

1. Current trazodone dose and timing - Was it taken at least 1 hour before bedtime with food? 2
2. Sleep pattern specifics - Is this sleep onset (can't fall asleep) or sleep maintenance (waking during night)?
3. Medication interactions - Check for SSRIs, SNRIs, or other serotonergic drugs that could cause problems 2
4. Cardiac history - Trazodone causes QT prolongation; assess for heart disease 2
5. Recent life stressors or new medications in the past week

Recommended Pharmacologic Switch

Based on her sleep pattern:

For Sleep Maintenance Problems (waking during the night):

• Low-dose doxepin 3-6 mg at bedtime 1
  • This is FDA-approved specifically for sleep maintenance
  • Safer side effect profile in elderly compared to benzodiazepines
  • Start at 3 mg in this 79-year-old

For Sleep Onset Problems (difficulty falling asleep):

• Ramelteon 8 mg taken 30 minutes before bedtime 1
  • Melatonin receptor agonist with no abuse potential
  • No significant motor or cognitive impairment 3
  • Particularly appropriate for elderly patients

Alternative Options (if above unavailable):

• Eszopiclone 1 mg (start low in elderly; addresses both onset and maintenance) 1
• Zolpidem 5 mg (lower dose for women and elderly) 1

Critical Safety Considerations in This 79-Year-Old

Avoid benzodiazepines - Despite being FDA-approved, they carry excessive fall risk, cognitive impairment, and dependence risk in elderly patients 3

Do NOT use:

• Diphenhydramine (anticholinergic burden, falls) 1
• Over-the-counter melatonin (inconsistent quality, minimal efficacy) 1
• Continuing trazodone (guideline recommends against it) 1

Non-Pharmacologic Interventions to Implement Simultaneously

The 2009 JAGS guidelines emphasize these evidence-based behavioral interventions for elderly patients 3:

Stimulus Control (most important):

• Go to bed only when sleepy
• Leave bedroom if not asleep within 20 minutes
• Use bedroom only for sleep and sex (no TV, reading, or worrying in bed)
• Maintain consistent wake time every morning regardless of sleep duration
• Eliminate daytime napping or limit to 30 minutes before 2 PM

Sleep Hygiene Essentials:

• Avoid caffeine, nicotine, and alcohol (all fragment sleep)
• No heavy exercise within 2 hours of bedtime
• Develop a 30-minute wind-down ritual before bed
• Keep bedroom dark, quiet, and comfortable

Taper Strategy for Trazodone

Since she's only been on it one week, you can discontinue abruptly without significant withdrawal risk 2. However, if she's been on it longer than stated:

• Reduce by 25-50 mg every 3-5 days
• Start new hypnotic when trazodone reaches 25 mg or less
• Monitor for rebound insomnia or anxiety during transition

Common Pitfalls to Avoid

1. Don't add another sedating medication on top of trazodone - This increases fall risk exponentially in elderly patients
2. Don't assume one week of poor sleep requires chronic medication - Acute insomnia may resolve with behavioral interventions alone
3. Don't prescribe standard adult doses - Always start with lowest available dose in elderly (pharmacokinetic changes with age) 3
4. Don't ignore underlying causes - Depression, pain, nocturia, sleep apnea, or restless legs could be primary problems

Follow-Up Timeline

• Week 1-2: Assess response to new medication and behavioral interventions
• Week 4: If no improvement, consider polysomnography to rule out sleep apnea or periodic limb movements
• Month 3: Attempt to taper hypnotic if sleep has normalized, maintaining behavioral strategies

The evidence strongly supports discontinuing trazodone in favor of FDA-approved agents with better safety profiles in elderly patients, combined with structured behavioral interventions that have demonstrated efficacy in this age group 3, 1, 4.